ReviewFrontiers in pharmacology2022

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection.

Wujun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.